A method for multi-site editing and efficient screening of Kluyveromyces lactis genome
Through the CRISPR/Cas9 system and optimized sgRNA design, combined with donor DNA and KU80 knockout, the problem of low genome editing efficiency of Kluvia lactate is solved, efficient single-gene and multi-gene editing is achieved, and genome editing is significantly improved. efficiency and expression level.
Patent Information
- Application Number
- CN202410662454.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-27
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-05-27
AI Technical Summary
The genome editing efficiency of Kluvia lactate is mainly due to its active non-homologous terminal junction repair mechanism, which prevents linear repair DNA fragments from being effectively integrated at the target genomic loci, and the lack of efficient gene editing and screening systems limits its Development and application of expression systems.
Using a CRISPR/Cas9-based gene editing system, screening and optimizing sgRNA targets, donor DNA and multigene editing in series and parallel, sgRNA was designed to take TGG as the PAM target, and combine Cas9 nuclease and donor DNA for the same Source recombination editing, optimize KU80 knockout and donor DNA homologous arm length and concentration, and improve gene editing efficiency.
The homologous recombination and editing efficiency of single genes reached 95%, and the homologous recombination and editing efficiency of three genes reached 42%, significantly improving the effect of genome editing such as integration and knockout, and improving the gene editing efficiency of Kluvia lactate and expression level.
Smart Images

Figure CN118389516B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a method for multi-site editing and efficient screening of Kluyveromyces lactis genome, belonging to the technical field of gene editing. Background Art
[0002] Kluyveromyces lactis is a typical unconventional yeast that has been certified by the FDA as a food-safe microorganism (GRAS). In recent years, Kluyveromyces lactis has been widely used in the efficient production of industrial enzymes and pharmaceutical proteins due to its efficient protein expression ability and post-translational modification function, playing an important role in the fields of food and medicine. However, the lack of genetic manipulation methods and the unclear protein secretion mechanism limit the development and application of Kluyveromyces lactis expression systems. Therefore, the establishment of efficient genome editing tools is conducive to faster and better development of Kluyveromyces lactis cell factories and the analysis of their efficient expression mechanisms.
[0003] As a gene editing tool, the CRISPR system is based on base pairing of non-coding single guide RNA (sgRNA) with the DNA target sequence, using the Cas9 endonuclease to introduce site-specific double-strand breaks (DSBs) in the target site, and finally repairing the DSBs through homologous recombination (HR), allowing for marker-free destruction, deletion or insertion, and achieving precise editing of the target gene. As an unconventional yeast, Kluyveromyces lactis has a very active non-homologous end joining (NHEJ) repair mechanism, and the linear repaired DNA fragments cannot be effectively integrated at the target genomic site, which makes precise genome editing inefficient. Therefore, the establishment of a multi-gene editing and efficient screening system without screening markers is of great significance for the development of Kluyveromyces lactis expression system. Summary of the invention
[0004] To solve the above problems, the present invention provides a CRISPR / Cas9-based Kluyveromyces lactis gene editing system, which screens and optimizes sgRNA target sites, donor DNA, and multi-gene editing in series and parallel, so that the gene editing efficiency is as high as 95%. Based on this, the present invention also uses this method for gene integration and improves the expression level of the integrated gene.
[0005] The first object of the present invention is to provide a sgRNA for editing the Kluyveromyces lactis gene ADE2, the sequence of the sgRNA being shown in SEQ ID NO.1.
[0006] The second object of the present invention is to provide a recombinant expression vector containing the sgRNA.
[0007] The third object of the present invention is to provide a gene editing system for Kluyveromyces lactis, wherein the gene editing system comprises at least one sgRNA expression frame and a Cas9 nuclease expression frame, wherein the sgRNA in the sgRNA expression frame is designed with TGG in the target gene as the PAM target.
[0008] Furthermore, the sgRNA expression frame contains the sgRNA. Of course, the expression frame also contains various elements for expression.
[0009] Furthermore, when used for homologous recombination editing, the gene editing system also includes donor DNA.
[0010] Furthermore, the donor DNA has homology arms of 500-1000 bp upstream and downstream respectively.
[0011] Furthermore, in the gene editing system, the usage ratio of the editing plasmid to the donor DNA is 8:3-12, and the concentration of the donor DNA is 75-300 ng / μL.
[0012] Furthermore, the Cas9 nuclease expression frame contains the Cas9 nuclease shown in SEQ ID NO.2.
[0013] Furthermore, the recombinant expression vector also contains a hammerhead ribozyme located upstream of the sgRNA and a hepatitis D virus ribozyme located downstream of the sgRNA.
[0014] Furthermore, the sequences of the hammerhead ribozyme and the hepatitis D virus ribozyme are shown in SEQ ID NO. 3-4, respectively.
[0015] Furthermore, the gene editing system is used for single gene editing or multi-gene editing.
[0016] Furthermore, when used for multi-gene editing, TGG of different target genes is selected as the PAM target to design sgRNA and construct multiple parallel sgRNA expression frames.
[0017] A fourth object of the present invention is to provide a method for gene editing of Kluyveromyces lactis, comprising the following steps:
[0018] S1. Design sgRNA with TGG of the target gene as the PAM target and construct one sgRNA expression frame or multiple parallel sgRNA expression frames;
[0019] S2. Introduce the gene editing system containing the sgRNA expression frame and the Cas9 nuclease expression frame described in S1 into a Kluyveromyces lactis host for gene editing.
[0020] Furthermore, in step S2, the gene editing system also contains donor DNA.
[0021] Furthermore, the Kluyveromyces lactis is a modified or unmodified strain, and the modification includes but is not limited to knocking out the KU80 gene.
[0022] The fifth object of the present invention is to provide the application of the sgRNA, recombinant expression vector, gene editing system or gene editing method in the transformation of Kluyveromyces lactis to improve the gene editing efficiency of Kluyveromyces lactis.
[0023] Beneficial effects of the present invention:
[0024] The present invention screened the gRNA target and found that when the gRNA was designed with TGG as the PAM sequence of the target gene, the total editing efficiency and the homologous recombination editing efficiency were improved. Furthermore, the present invention optimizes KU80 knockout, donor DNA homologous arm length, and donor DNA addition concentration to improve the efficiency of single gene homologous recombination editing; in addition, by comparing the series and parallel connection of sgRNA, a method more suitable for Kluyveromyces lactis multi-gene homologous recombination editing was screened out. Finally, the present invention achieves a single gene homologous recombination editing efficiency of 95%, and a three-gene homologous recombination editing efficiency of 42%, which has effect advantages in genome editing such as genome integration and genome knockout. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is the plasmid map of PUDP00A.
[0026] Figure 2 This is a diagram showing the effect of mutation in the ADE2 gene of Kluyveromyces lactis morphology.
[0027] Figure 3 Functional validation of the CRISPR-Cas9 system in Kluyveromyces lactis.
[0028] Figure 4 To investigate the gene editing efficiency of targeting different positions of ADE2.
[0029] Figure 5 The effect of donor DNA concentration on editing efficiency.
[0030] Figure 6 The effect of donor DNA homology arm length on gene knockout efficiency.
[0031] Figure 7 This is the plasmid map of the multi-gene editing system.
[0032] Figure 8 To investigate the multi-gene editing efficiency of the CRISPR-Cas9 system in Kluyveromyces lactis.
[0033] Fig. 9This is the result of multiple copies of lactase integration. DETAILED DESCRIPTION
[0034] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0035] The materials involved in the present invention are as follows:
[0036] (I) Culture medium
[0037] YPD medium: 20 g glucose, 10 g yeast powder, 20 g peptone, add water to make up to 1 L.
[0038] LB medium: 10 g peptone, 5 g yeast powder, 10 g NaCl, add water to make up to 1 L.
[0039] YCB medium: 11.7 g yeast basal carbon source, 15-20 g agar, add water to 1 L, and add acetamide to a final concentration of 5 mmol / L after sterilization. -1 .
[0040] (II) Reagent formula
[0041] Yeast treatment solution: 10 mM lithium acetate, 10 mM Tris HCl (pH 7.5), 0.6 M sorbitol.
[0042] (3) Sequence
[0043] ADE2-sgRNA1: SEQ ID NO.1
[0044] SpCas9(D147YP411T):SEQ ID NO.2
[0045] Hammerhead (HH) ribozyme: SEQ ID NO.3
[0046] Hepatitis D virus (HDV) ribozyme: SEQ ID NO.4
[0047] sgRNA1ac12: SEQ ID NO.5
[0048] sgRNA1ac4: SEQ ID NO.6
[0049] ADE2, LCA12, LCA4: SEQ ID NO.7-9
[0050] Endogenous lactase: SEQ ID NO.10
[0051] Example 1: Construction and validation of the Kluyveromyces lactis CRISPR system
[0052] (1) Construction of CRISPR / Cas9 system
[0053] pUDP00A contains a fungal acetamidase (amdS) selection marker cassette controlled by the ADH1 promoter and terminator from S. cerevisiae, SpCas9 (D147YP411T) controlled by the TEF1 promoter from A. adeninivorans and the PHO5 terminator from S. cerevisiae, a pan-genomic yeast replication origin panARS (OPT), a gRNA expression cassette with a BsaI cloning site, and the E. coli pbr322 replication origin and the bla gene for ampicillin selection; the gRNA expression cassette contains upstream hammerhead (HH) ribozyme and downstream hepatitis delta virus (HDV) ribozyme flanks to facilitate cloning of new sgRNA targeting sites by Golden Gate assembly. The structure is controlled by the RNA polymerase II promoter TDH3 and CYC1 terminator from Saccharomyces cerevisiae. A mature gRNA is released when the ribozyme self-cleaves; the pD147YP411T gene is expressed in 1% sgRNA and 1% sgRNA is expressed in 1% sgRNA. The pD147YP411T gene is expressed in 1% sgRNA and 1% sgRNA is expressed in 1% sgRNA. The pD147YP411T gene is expressed in 1% sgRNA and 1% sgRNA is expressed in 1% sgRNA. Kit, using PUDP00A as the vector backbone, introduced the 20bp sgRNA targeting sequence into the backbone plasmid to obtain the CRISPR / Cas9 module plasmid PUDP00A (such as Figure 1 ). Among them, the PUDP00A vector backbone is a public vector (PUDP025 plasmid purchased from Addgene, https: / / www.addgene.org / 103874 / , reference Juergens et al FEMS Yeast Res. 2018May 1; 18(3).pii:4847887.doi:10.1093 / femsyr / foy012.), but we replaced the hygromycin resistance expression frame on the original plasmid with the amds expression frame to obtain the PUDP00A vector, that is, the plasmid was changed from resistance screening to nutritional screening.
[0054] (2) Construction of donor DNA
[0055] A 2000bp fragment at both ends of the target site of the target gene is amplified from the genome, connected to the intermediate vector through one-step cloning, and the correct plasmid is obtained after transformation. This is used as a template to amplify a fragment with homologous arms of the required length to obtain a gene knockout donor fragment.
[0056] (3) Preparation and transformation of Kluyveromyces lactis competent cells
[0057] a. Pick a single colony and inoculate it into 25 mL YPD liquid medium, and culture it at 30°C, 200 rpm for 24 hours. Take an appropriate amount of yeast seed liquid (2%) and transfer it to 50 mL liquid YPD medium until OD = 0.3, and continue to culture for 4-5 hours until OD = about 1.
[0058] b. Place the bacterial solution in an ice bath for 5 minutes, centrifuge at 4500 rpm for 5 minutes, and remove the supernatant.
[0059] c. Add 7 mL of yeast treatment solution and 35 uL of 2M DTT solution, let stand at room temperature for 20 min, centrifuge at 4°C, 4500 rpm for 3 min, and discard the supernatant.
[0060] d. Add 3 mL of pre-cooled 1 mol·L-1 sorbitol solution (18.218 g to 100 mL, final concentration 1 mol / L), gently resuspend the cells, centrifuge at 4°C, 4500 rpm for 3 min, discard the supernatant, and repeat this step once;
[0061] e. Add 800 μL of 1 mol·L-1 sorbitol solution, resuspend the cells, and dispense 75 μL into pre-cooled 1.5 mL centrifuge tubes;
[0062] f. Add 200 ng of editing plasmid and 300 ng of donor DNA fragment, mix gently with a pipette, and place on ice for 10 min;
[0063] g. Transfer the bacterial suspension in step e to a pre-cooled yeast electroporation cup (2 mm), 2000 V, 400 Ω, electric shock 5 ms;
[0064] h. Wash all the bacterial suspension in the electroporation cup into a 1.5 mL centrifuge tube with 1 mL of 1 M sorbitol solution;
[0065] i. After incubation at 30°C for 1-2 hours, centrifuge at 5000 rpm for 1 minute, discard part of the supernatant, and resuspend the cells;
[0066] j. Spread on selection plates, culture at 30℃ for 3-4 days, and then pick out single colonies for verification.
[0067] (4) Functional verification of the CRISPR / Cas9 system
[0068] The constructed editing plasmid was transformed into Kluyveromyces lactis GG799 to evaluate the editing efficiency of the CRISPR / Cas9 system. In the statistics of editing efficiency based on the ADE2 morphological gene indication, the ratio of single colonies with color changes in the transformation plate (colonies with ADE2 gene disruption turned pink due to the accumulation of intermediate products) to the entire colony A1 / A2 was first counted, and A1 / A2 was directly used as the total editing efficiency of the morphological gene (such as Figure 2). A certain number of single colonies with color changes were picked for colony PCR and sequencing verification, and the ratio B1 / B3 containing single-point replacement or insertion was obtained as the NHEJ editing efficiency, and the ratio B2 / B3 of target gene knockout was obtained as the HR editing efficiency. The final NHEJ editing efficiency is eN=(A1 / A2)*(B1 / B3)*100%, and the HR editing efficiency is eH=(A1 / A2)*(B2 / B3)*100%. PUD-Cas9 (without sgRNA expression cassette), PUD-sgRNA (without Cas9) and PUD (without Cas9 and sgRNA expression cassettes) were constructed using the Gibson assembly reaction for negative control. The experimental results showed that the total editing efficiency was 58.3% without providing donor DNA. When donor DNA was provided, the total editing efficiency was 72.0% ( Figure 3 ).
[0069] Example 2: Optimization of Kluyveromyces lactis ADE2 gene targeting position
[0070] All 20 bp Cas9-gRNA target sequences used in this study are shown in Table 1. Using ADE2 as the target gene, the total editing efficiency of the system was evaluated according to the steps of Example 1. sgRNAs were selected using an online website ( http: / / www.rgenome.net ), excluding any target sequences outside the target (defined as mismatched sequences in the entire genome). Candidate target sequences for ADE2 were predicted based on GC content (recommended range 20% to 80%) and predicted out-of-frame scores (recommended calculated microhomology out-of-frame scores of 30 or more). Four sequences from the forward or antisense strand with PAM sites of TGG, AGG, CGG, and GGG were selected as target sites. Finally, four sgRNAs were selected to synthesize 20bp targeting sequences, which were inserted into plasmid pUDP00A through primers to obtain plasmid PUD-sgRNA1-4-ADE2.
[0071] The total editing efficiencies of PUD-sgRNA1-4-ADE2 were 82.3%, 58.3%, 72.8%, and 26.7%, respectively (Table 1, Figure 4 ).
[0072] Table 1 Target gene sequences
[0073]
[0074]
[0075] Example 3: Optimization of homologous recombination efficiency of single gene knockout
[0076] Knockout of Kluyveromyces lactis KU80 and the effects of homology arm length and concentration on homologous recombination efficiency:
[0077] KU80-sgRNA was designed according to Table 2 to knock out the KU80 gene in Kluyveromyces lactis GG799, and KU80 knockout recombinant bacteria were obtained for subsequent analysis to determine the ADE2 editing efficiency in the wild-type strain and the recombinant strain.
[0078] A 2000 bp fragment at both ends of the ADE2 target site was amplified from the genome, and connected to the intermediate cloning vector pMD19-T by one-step cloning. After transformation, the correct T-ADE2-TY plasmid was obtained, and used as a template to amplify fragments of ADE2 homology arms with different homology arm lengths (1000 bp, 750 bp, 500 bp, 250 bp, 100 bp). At the same time, fragments of ADE2 homology arms with different concentrations (300 ng, 150 ng, 75 ng, 50 ng) were prepared as donor DNA. The control group without adding donor DNA was used to evaluate the effect of homology arm length and concentration on ADE2 gene knockout (the rest of the steps were the same as in Example 1, and sgRNA 1 obtained in Example 2 was selected as sgRNA).
[0079] The experimental results showed that the homologous recombination efficiency of the KU80 knockout strain was improved compared with the wild-type strain. Moreover, when the donor DNA length was controlled to 750 bp and the concentration was 300 ng, the homologous recombination efficiency of the KU80 knockout strain was increased from 45.3% to 89.0% compared with the wild-type strain ( Figure 5 ); When the donor DNA concentration was controlled at 300 ng, the homologous recombination efficiency of KU80 knockout strains with different donor lengths increased from 38.1% to 95.2%, with 1000 bp upstream and downstream being optimal ( Figure 6 ).
[0080] Therefore, in subsequent multi-gene editing, 1000 bp homology arms upstream and downstream were used to construct DNA donors, with an added amount of 200 ng editing plasmid and 300 ng donor DNA, and ADE2-sgRNA selected sgRNA1 to optimize the homologous recombination efficiency.
[0081] Table 2 Target gene sequences
[0082]
[0083] Example 4: Editing of multiple genes in Kluyveromyces lactis (eg Figure 7 )
[0084] Method 1: Construction of multi-sgRNA tandem editing plasmid and multi-gene editing:
[0085] Select three genomic target sites ADE2, LAC12 and LAC4 to insert the company's synthesized ribozyme flanking sgRNA (HH-sgRNAade2-HDV-HH-sgRNA1ac12-HDV-HH-sgRNA1ac4-HDV) triple array into the plasmid PUD-Cas9. The structure is controlled by the RNA polymerase II promoter ScTDH3 and the ScCYC1 terminator. The obtained plasmid is named PUD-3sgRNA for simultaneous targeting of these three genomic sites. This sgRNA delivery method knocks out two (ADE2, LAC12) or three genes in one step, using 200ng PUD-3sgRNA and 300ng of donor DNA each time for co-transformation. The homologous recombination editing efficiency is obtained according to the calculation method in Example 1. The results showed that based on color-assisted screening, the simultaneous editing efficiency of two genes and three genes in wild-type Kluyveromyces lactis was 52.8% and 19.3%, and the simultaneous editing efficiency of two genes and three genes in KU80 knockout bacteria was 75.3% and 36.0% ( Figure 8 ).
[0086] Method 2: Construction of linear editing plasmids with multiple sgRNAs in parallel and multi-gene editing:
[0087] For multiple linear gRNA cassettes, the structure of each linear RNA cassette is controlled by the ScTDH3 promoter and the ScCYC1 terminator, and has 500bp of flanking homology to the end of the linearized backbone plasmid pUD-Cas9 to facilitate re-circularization in vivo by homologous recombination. In this sgRNA delivery mode, 200ng of linearized sgRNA cassettes, 200ng of linearized pUD-cas9 plasmids, and 300ng of donor DNA were used for co-transformation each time. The results showed that based on color-assisted screening, the simultaneous editing efficiency of two genes (ADE2, LAC12) and three genes of wild-type lactic acid Kluyveromyces was 32.7% and 34.6%, and the simultaneous editing efficiency of two genes and three genes of KU80 knockout bacteria was 80% and 42%. (Table 3, Figure 8 ) Table 3 Linearized delivery mode structure
[0088]
[0089]
[0090]
[0091]
[0092]
[0093] Example 5: Multiple copies of lactase integrated into Kluyveromyces lactis
[0094] The expression cassette of endogenous lactase was integrated into the ADE2 and LAC12 sites of Kluyveromyces lactis using the CRISPR-Cas9 system. The sgRNA-ADE2 and sgRNA-LAC12 targeting two genomic sites were designed and constructed using the method 2 in Example 4, and the integration donor DNA fragment was constructed by the method in Example 1, and the dual-site lactase integration recombinant strain was obtained by electroporation and screening. The results showed that multi-copy integration was beneficial to improving the expression level of lactase, and the expression level of the dual-copy lactase was 3.4 times higher than that of the control group. (Table 4, Fig. 9 ).
[0095] Table 4 Target gene sequences
[0096]
[0097] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.
Claims
1. A sgRNA for editing the Kluyveromyces lactis gene ADE2, characterized in that: The sequence of the sgRNA is shown in SEQ ID NO.
1.
2. A recombinant expression vector containing the sgRNA according to claim 1.
3. A gene editing system for Kluyveromyces lactis, characterized in that: The gene editing system comprises at least one sgRNA expression frame and a Cas9 nuclease expression frame, the sgRNA in the sgRNA expression frame is designed with TGG in the target gene as the PAM target, and the sgRNA expression frame contains the sgRNA according to claim 1.
4. The gene editing system according to claim 3, characterized in that The gene editing system also includes donor DNA.
5. The gene editing system according to claim 4, characterized in that: The donor DNA has 500-1000bp homology arms upstream and downstream respectively; in the gene editing system, the usage ratio of the editing plasmid to the donor DNA is 8:3-12.
6. The gene editing system according to claim 3, characterized in that: When performing multi-gene editing, sgRNAs are designed separately based on the TGG of multiple target genes as PAM targets, and multiple parallel sgRNA expression frames are constructed.
7. A method for gene editing of Kluyveromyces lactis, characterized in that: The gene editing system according to any one of claims 3 to 6 is introduced into Kluyveromyces lactis for editing.
8. The method according to claim 7, characterized in that The lactic acid Kluyveromyces is a modified or unmodified strain, and the modification includes knocking out the KU80 gene.
9. Use of the sgRNA according to claim 1, the recombinant expression vector according to claim 2, the gene editing system according to any one of claims 3 to 6, or the gene editing method according to claim 7 or 8 in the transformation of Kluyveromyces lactis.
Citation Information
Patent Citations
Efficient CRISPR / Cas (Clustered Regulatory Interspaced Short Palindromic Repeats / CRISPR associated) 9 gene editing system for Kluyveromyces optimization
CN107574179A
Genome editing vector and application
CN117467693A
